Recording of the Third Quarter 2017 Investor Conference Webinar

on January 15, 2018

On January 11 JSC Olainfarm organized its Investor Conference Online Webinar. During the webinar the member of the management board of JSC Olainfarm Salvis Lapiņš analyzed the financial results of third quarter 2017 and informed about the other recent activities within the company.

During the webinar, Salvis Lapiņš received a question on the amount of receivables overdue for 90 and more days that are unprovided for. The amount totaled 1.4 million euros as of October 1st, 2017.

The recorded JSC Olainfarm webinar is available online:, and the presentation, demonstrated during the webinar, is available in the previously published company’s announcement:

Olainfarm thanks all participants, who joined the webinar, and encourages everybody to follow company’s announcements to get information on the next webinar!


JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with 45 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 50 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.


Information prepared by:
Salvis Lapins
JSC Olainfarm
Member of the Management Board
Rupnicu iela 5, Olaine, Latvia, LV 2114
Phone: +371 6 7013 717
Fax: +371 6 7013 777

Share this post:
Eva DombrovskaRecording of the Third Quarter 2017 Investor Conference Webinar